West Pharmaceutical Services, Inc [WST] stock prices are down -2.10% to $254.48 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The WST shares have lost -0.20% over the last week, with a monthly amount glided 4.08%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
West Pharmaceutical Services, Inc [NYSE: WST] stock has seen the most recent analyst activity on September 15, 2025, when Rothschild & Co Redburn initiated its Buy rating and assigned the stock a price target of $311. Previously, Barclays started tracking the stock with Equal Weight rating on June 24, 2025, and set its price target to $245. On March 18, 2025, Evercore ISI initiated with a Outperform rating and assigned a price target of $275 on the stock. Deutsche Bank upgraded its rating to a Buy but stick to its price target of $250 on February 14, 2025. Citigroup initiated its recommendation with a Buy and recommended $400 as its price target on January 08, 2025. In a note dated December 12, 2024, UBS upgraded a Buy rating on this stock and boosted its target price from $350 to $390.
The stock price of West Pharmaceutical Services, Inc [WST] has been fluctuating between $187.43 and $352.33 over the past year. Currently, Wall Street analysts expect the stock to reach $278 within the next 12 months. West Pharmaceutical Services, Inc [NYSE: WST] shares were valued at $254.48 at the most recent close of the market. An investor can expect a potential return of 9.24% based on the average WST price forecast.
Analyzing the WST fundamentals
The West Pharmaceutical Services, Inc [NYSE:WST] reported sales of 2.96B for trailing twelve months, representing a surge of 9.15%. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.21%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.18 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 251.90 points at the first support level, and at 249.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 257.85, and for the 2nd resistance point, it is at 261.22.
Ratios To Look Out For
It’s worth pointing out that West Pharmaceutical Services, Inc [NYSE:WST]’s Current Ratio is 2.78. As well, the Quick Ratio is 2.08, while the Cash Ratio is 0.84. Considering the valuation of this stock, the price to sales ratio is 6.18, the price to book ratio is 6.25 and price to earnings (TTM) ratio is 38.12.
Transactions by insiders
Recent insider trading involved Witherspoon Charles, VP & Treasurer, that happened on Oct 29 ’24 when 703.0 shares were sold.
